Abstract
N-methyl-D-aspartate receptor antagonists (e.g., ketamine) have rapid antidepressant effects in treatment-resistant depression (TRD). Ongoing studies demonstrate that nitrous oxide, an inhalational general anesthetic and N-methyl-D-aspartate receptor antagonist, may be a rapidly acting TRD treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
